JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Inhibition of PI3K/AKT Signaling Pathway Enhances Cordycepin-Induced Apoptosis in Human Gastric Cancer Cells
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Inhibition of PI3K/AKT Signaling Pathway Enhances Cordycepin-Induced Apoptosis in Human Gastric Cancer Cells
Lee, Hye Hyeon; Jeong, Jin-Woo; Choi, Yung Hyun;
  PDF(new window)
 Abstract
The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway plays a crucial role in cancer occurrence by promoting cell proliferation and inhibiting apoptosis. In the present study, we evaluated the effect of a PI3K inhibitor, LY294002, on the chemosensitivity of gastric cancer cells to cordycepin, a predominant functional component of the fungus Cordyceps militaris, in AGS human gastric cancer cells and investigated possible underlying cellular mechanisms. Our results revealed that cordycepin inhibited viability of AGS cells in a concentration-dependent manner and induced apoptosis, as determined by apoptotic cell morphologies and fluorescence-activated cell sorting analysis associated with attenuated activation of the PI3K/Akt signaling pathway. Treatment with cordycepin in combination with a subtoxic concentration of LY294002 enhanced cordycepin-induced cytotoxicity and apoptotic potentials in AGS cells. Sensitization of LY294002 to cordycepin-induced apoptosis was accompanied by activation of caspases (caspases-3, -8, and -9) and was concomitant with poly(ADP-ribose) polymerase cleavage. Moreover, LY294002 up-regulated pro-apoptotic Bax and enhanced truncation of Bid in cordycepin-treated AGS cells, which was connected with increased loss of mitochondrial membrane potential and release of cytochrome c from mitochondria to the cytosol. Taken together, these results indicate that inhibition of the PI3K/Akt signaling pathway could augment cordycepin-induced apoptosis in human gastric cancer cells by up-regulating caspase activity through mitochondrial dysfunction.
 Keywords
cordycepin;PI3K/Akt;AGS cells;apoptosis;caspase;
 Language
Korean
 Cited by
 References
1.
Xiao JH, Zhong JJ. 2007. Secondary metabolites from Cordyceps species and their antitumor activity studies. Recent Pat Biotechnol 1: 123-137. crossref(new window)

2.
Cunningham KG, Manson W, Spring FS, Hutchinson SA. 1950. Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) Link. Nature 166: 949.

3.
Nair CN, Owens MJ. 1974. Preliminary observations pertaining to polyadenylation of rhinovirus RNA. J Virol 13: 535-537.

4.
Thomadaki H, Tsiapalis CM, Scorilas A. 2005. Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction. Biol Chem 386: 471-480.

5.
Thomadaki H, Scorilas A, Tsiapalis CM, Havredaki M. 2008. The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner. Cancer Chemother Pharmacol 61: 251-265.

6.
Chen LS, Stellrecht CM, Gandhi V. 2008. RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells. Br J Haematol 140: 682-691. crossref(new window)

7.
Chen Y, Chen YC, Lin YT, Huang SH, Wang SM. 2010. Cordycepin induces apoptosis of CGTH W-2 thyroid carcinoma cells through the calcium-calpain-caspase 7-PARP pathway. J Agric Food Chem 58: 11645-11652. crossref(new window)

8.
Choi S, Lim MH, Kim KM, Jeon BH, Song WO, Kim TW. 2011. Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor. Toxicol Appl Pharmacol 257: 165-173. crossref(new window)

9.
Jeong JW, Jin CY, Park C, Hong SH, Kim GY, Jeong YK, Lee JD, Yoo YH, Choi YH. 2011. Induction of apoptosis by cordycepin via reactive oxygen species generation in human leukemia cells. Toxicol In Vitro 25: 817-824. crossref(new window)

10.
Li Y, Li R, Zhu S, Zhou R, Wang L, DU J, Wang Y, Zhou B, Mai L. 2015. Cordycepin induces apoptosis and autophagy in human neuroblastoma SK-N-SH and BE(2)-M17 cells. Oncol Lett 9: 2541-2547.

11.
Lee HH, Kim SO, Kim GY, Moon SK, Kim WJ, Jeong YK, Yoo YH, Choi YH. 2014. Involvement of autophagy in cordycepin- induced apoptosis in human prostate carcinoma LNCaP cells. Environ Toxicol Pharmacol 38: 239-250. crossref(new window)

12.
Lee HH, Park C, Jeong JW, Kim MJ, Seo MJ, Kang BW, Park JU, Kim GY, Choi BT, Choi YH, Jeong YK. 2013. Apoptosis induction of human prostate carcinoma cells by cordycepin through reactive oxygen species-mediated mitochondrial death pathway. Int J Oncol 42: 1036-1044.

13.
Lee SY, Debnath T, Kim SK, Lim BO. 203. Anti-cancer effect and apoptosis induction of cordycepin through DR3 pathway in the human colonic cancer cell HT-29. Food Chem Toxicol 60: 439-447. crossref(new window)

14.
Fiandalo MV, Kyprianou N. 2012. Caspase control: protagonists of cancer cell apoptosis. Exp Oncol 34: 165-175.

15.
Hensley P, Mishra M, Kyprianou N. 2013. Targeting caspases in cancer therapeutics. Biol Chem 394: 831-843.

16.
Lavrik IN. 2000. Systems biology of apoptosis signaling networks. Curr Opin Biotechnol 21: 551-555.

17.
Fulda S, Debatin KM. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25: 4798-4811. crossref(new window)

18.
Duriez PJ, Shah GM. 1997. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol 75: 337-349. crossref(new window)

19.
Wang XA, Xiang SS, Li HF, Wu XS, Li ML, Shu YJ, Zhang F, Cao Y, Ye YY, Bao RF, Weng H, Wu WG, Mu JS, Hu YP, Jiang L, Tan ZJ, Lu W, Wang P, Liu YB. 2014. Cordycepin induces S phase arrest and apoptosis in human gallbladder cancer cells. Molecules 19: 11350-11365. crossref(new window)

20.
Liao Y, Ling J, Zhang G, Liu F, Tao S, Han Z, Chen S, Chen Z, Le H. 2015. Cordycepin induces cell cycle arrest and apoptosis by inducing DNA damage and up-regulation of p53 in Leukemia cells. Cell Cycle 14: 761-771. crossref(new window)

21.
Lee HH, Jeong JW, Lee JH, Kim GY, Cheong J, Jeong YK, Yoo YH, Choi YH. 2013. Cordycepin increases sensitivity of Hep3B human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by inactivating the JNK signaling pathway. Oncol Rep 30: 1257-1264.

22.
Chen YH, Hao LJ, Hung CP, Chen JW, Leu SF, Huang BM. 2014. Apoptotic effect of cisplatin and cordycepin on OC3 human oral cancer cells. Chin J Integr Med 20: 624-632. crossref(new window)

23.
Tian X, Li Y, Shen Y, Li Q, Wang Q, Feng L. 2015. Apoptosis and inhibition of proliferation of cancer cells induced by cordycepin. Oncol Lett 10: 595-599.

24.
Baik JS, Kwon HY, Kim KS, Jeong YK, Cho YS, Lee YC. 2012. Cordycepin induces apoptosis in human neuroblastoma SK-N-BE(2)-C and melanoma SK-MEL-2 cells. Indian J Biochem Biophys 49: 86-91.

25.
Chan CH, Jo U, Kohrman A, Rezaeian AH, Chou PC, Logothetis C, Lin HK. 2014. Posttranslational regulation of Akt in human cancer. Cell Biosci 4: 59. crossref(new window)

26.
Markman B, Tao JJ, Scaltriti M. 2013. PI3K pathway inhibitors: better not left alone. Curr Pharm Des 19: 895-906. crossref(new window)

27.
Singh SS, Yap WN, Arfuso F, Kar S, Wang C, Cai W, Dharmarajan AM, Sethi G, Kumar AP. 2015. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?. World J Gastroenterol 21: 12261-12273. crossref(new window)

28.
Shi M, Zhang H, Li M, Xue J, Fu Y, Yan L, Zhao X. 2011. Normal endometrial stromal cells regulate survival and apoptosis signaling through PI3K/AKt/Survivin pathway in endometrial adenocarcinoma cells in vitro. Gynecol Oncol 123: 387-392. crossref(new window)

29.
Michl P, Downward J. 2005. Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers. Z Gastroenterol 43: 1133-1139. crossref(new window)

30.
Almhanna K, Strosberg J, Malafa M. 2011. Targeting AKT protein kinase in gastric cancer. Anticancer Res 31: 4387-4392.

31.
Heavey S, O'Byrne KJ, Gately K. 2014. Strategies for cotargeting the PI3K/AKT/mTOR pathway in NSCLC. Cancer Treat Rev 40: 445-456. crossref(new window)

32.
Steelman LS, Stadelman KM, Chappell WH, Horn S, Bäsecke J, Cervello M, Nicoletti F, Libra M, Stivala F, Martelli AM, McCubrey JA. 2008. Akt as a therapeutic target in cancer. Expert Opin Ther Targets 12: 1139-1165. crossref(new window)

33.
Ye Q, Cai W, Zheng Y, Evers BM, She QB. 2014. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer. Oncogene 33: 1828-1839. crossref(new window)

34.
Tang C, Lu YH, Xie JH, Wang F, Zou JN, Yang JS, Xing YY, Xi T. 2009. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acidinduced HepG2 cell apoptosis. Anticancer Drugs 20: 249-258. crossref(new window)

35.
Yoeli-Lerner M, Toker A. 2006. Akt/PKB signaling in cancer: a function in cell motility and invasion. Cell Cycle 5: 603-605. crossref(new window)

36.
Jeong JW, Jin CY, Park C, Han MH, Kim GY, Moon SK, Kim CG, Jeong YK, Kim WJ, Lee JD, Choi YH. 2012. Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt. Int J Oncol 40: 1697-1704.

37.
Jang KJ, Kwon GS, Jeong JW, Kim CH, Yoon HM, Kim GY, Shim JH, Moon SK, Kim WJ, Choi YH. 2015. Cordyceptin induces apoptosis through repressing hTERT expression and inducing extranuclear export of hTERT. J Biosci Bioeng 119: 351-357. crossref(new window)

38.
Pan BS, Wang YK, Lai MS, Mu YF, Huang BM. 2015. Cordycepin induced MA-10 mouse Leydig tumor cell apoptosis by regulating p38 MAPKs and PI3K/AKT signaling pathways. Sci Rep 5: 13372. crossref(new window)

39.
Stennicke HR, Salvesen GS. 1999. Catalytic properties of the caspases. Cell Death Differ 6: 1054-1059. crossref(new window)

40.
Lavrik IN, Golks A, Krammer PH. 2005. Caspases: pharmacological manipulation of cell death. J Clin Invest 115: 2665-2672. crossref(new window)